Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/17363733

Blood 2007 Jul 1 110 1 313-22

Download in:

View as

General Info

PMID
17363733